Basel, Switzerland (ots/PRNewswire) - - For ex-US Media Only - Phase III ATLAS Study Achieves a New Milestone in Treating Advanced Lung Cancer Roche announced today that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer (NSCLC) who received Avastin(R) (bevacizumab) ...
Stichting Shell Reserves Compensation Foundation and Royal Dutch Shell plc
The Hague, The Netherlands (ots/PRNewswire) - The Hague - Today, the Amsterdam Court of Appeals has declared the Non-U.S. Settlement Agreement concerning the recategorisation by Shell of certain of its oil and gas reserves binding. The agreement provides relief in the amount of US$352.6 million to qualifying non-U.S. shareholders who bought Shell shares on any stock exchange outside the United States from 8 April 1999 ...
Basel, Switzerland (ots/PRNewswire) - - RIBBON-1 Study Confirms Benefit of Avastin in Treating HER2-Negative Breast Cancer - For Non-US, Non-UK and Non-Austrian Media Results from the phase III RIBBON-1 study presented today at ASCO showed that patients with advanced HER2-negative breast cancer ...
Collegeville, Pennsylvania (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced preliminary data from two ongoing studies, one evaluating neratinib (HKI-272) in combination with trastuzumab (Herceptin(R), Roche) in HER-2 positive (ErbB-2 positive) breast cancer, and ...
Huizingen, Belgium (ots/PRNewswire) - RealDolmen, the independent single source ICT solutions provider and knowledge company, announces results for the fiscal year ended 31 March 2009, showing good growth across all metrics. Highlights of the year - Turnover up 5,6% - Operational result before nonrecurring items (REBIT) up 7,0 %, with REBIT margins up to 6,0%, despite incurred integration costs - ...
Huntington Beach, California, and Amsterdam (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnostic tests be held to one ...
Ottawa, Canada and Fleurus, Belgium (ots/PRNewswire) - - Site to Provide Fluorodeoxyglucose (F-18 FDG) for use in Earlier Detection of Disease and Therapy Management MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced the opening of a facility in Fleurus, Belgium for the production ...
London (ots/PRNewswire) - - For Healthcare and Pharmaceutical Correspondents Only - NICE Recommends Considering DPP-4 Inhibitors as a Second Line Treatment Option in Appropriate Patients Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A., Canada, and Japan Boehringer Ingelheim announced today that it will become the founding sponsor of the World Stroke Academy, a novel training initiative for stroke professionals being developed by the World Stroke ...
San Jose, California (ots/PRNewswire) - - maXTouch represents the market's most advanced Touchscreen Technology for Mobile Phones, Netbooks and other Electronic Devices Atmel(R) Corporation (Nasdaq: ATML) announced today a new fully integrated capacitive touchscreen technology - maXTouch(TM) - providing touchscreen performance which significantly exceeds ...
Huntington Beach, California and Amsterdam (ots/PRNewswire) - - Agendia Increases U.S. Footprint with Domestic Executive Team and Operations Agendia, a world leader in molecular cancer diagnostics, today announced the opening of its U.S. clinical genomics laboratory in Huntington Beach, CA. The laboratory is fully-licensed and compliant with the Clinical Laboratory Improvements Amendments (CLIA) as administered ...
Basel, Switzerland (ots/PRNewswire) - - Mircera Maintained Haemoglobin Levels in Significantly More Patients With CKD on Dialysis Data from the first head-to-head study in patients with chronic kidney disease (CKD) on dialysis who need treatment for renal anaemia have demonstrated that Mircera(R) (methoxy ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") announced the closing of its (i) private offer to exchange, for each $100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes due 2016 (the "Existing Notes"), one of its units (the "New ...
Abbotsford, Canada (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) is pleased to advise that it has acquired a 49% equity position in Luapula Mineral Ltd, a Zambian registered company which has legal title to 1,000 hectare Prospecting Permit (10 sq kms) within the Luapula area. President and CEO of ICS, Graham Chisholm comments: "This acquisition flows from a MOU between ATJ Natural Resources Ag, of Belize ...
Huntington Beach, California and Amsterdam (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced that leading researchers from Agendia, the University of California San Francisco and the Netherlands Cancer Institute will present data from multiple studies at the American ...
Houston, Texas (ots/PRNewswire) - - Using AVEVA PDMS Technology, Company Fast Tracks World's Largest Energy Projects AVEVA (LSE:AVV) today announced that a major client, Alliance Wood Group Engineering (Alliance) received FIATECH's 2008 Celebration of Engineering & Technology Innovation (CETI) Award in the category of Automated Design. The company uses AVEVA's PDMS solution to plan and execute its ultra-deep ...
Astellas Pharma Europe Limited
Prague (ots/PRNewswire) - - Ointment (Tacrolimus Monohydrate) in a New Twice-Weekly Regimen can Help Prevent Eczema Flares Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. ...
San Jose, California (ots/PRNewswire) - - Subscription license grants Atmel access to ARM Cortex processor IP Atmel(R) Corporation (Nasdaq: ATML) and ARM [(LSE: ARM); (Nasdaq: ARMH)] today announced an extension to their strategic relationship with a new subscription license agreement. Under the terms of the agreement, Atmel gains access to a number of ...
Helsinki (ots/PRNewswire) - - In Vitro Studies Presented at EWMA Conference Compare ConvaTec Dressings With Foams and Alginates (1-4) Researchers with ConvaTec Wound Therapeutics presented a series of in vitro studies demonstrating the advanced features and fluid handling capacity of the company's proprietary dressings containing Hydrofiber(R) Technology ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of a new AVR(R) 8-bit microcontroller for automotive LIN networking applications. The ATtiny87 is the second device of a LIN-dedicated low pin-count family specially optimized for cost-sensitive LIN ...
Milton Keynes, England (ots/PRNewswire) - The world-leading plasma lamp technology developed by UK lighting company Ceravision has been further enhanced through a joint development programme with Swedish microwave engineering firm Dipolar AB. The collaboration has produced a power supply that is ultra-efficient, very cost-effective and allows the use of ...
San Jose, California (ots/PRNewswire) - - New Device Offers Immediate Cost Savings to Customer with Low Memory Requirements Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of a new System-in-Package (SiP) solution for LIN automotive networking applications. The ATA6616, featuring ...
San Jose, California (ots/PRNewswire) - - US$19.99 kit allows developers and potential customers to evaluate the capabilities of CryptoAuthentication for preventing counterfeiting of medical and electronic consumables, maintain authenticity of end-product firmware, and protect sensitive transmitted data. ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") today announced the results of its (i) private offer to exchange, for each US$100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes due 2016 (the "Existing Notes"), one of its units ...
DAIICHI SANKYO EUROPE GmbH and SHARE
Munich (ots/PRNewswire) - - Investigating the Real Burden of Hypertension, Addressing the Challenges of Getting to Blood Pressure Goal and SHARE(ing) the Knowledge (http://www.SHARE-hypertension.com) The SHARE steering committee announce the launch of Supporting Hypertension Awareness & Research Europe-wide (SHARE) program on World Hypertension Day 2009 ...
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Media Only - Boehringer Ingelheim's LUX-Lung Programme Moves Forward With New Studies Revealing the Potential of BIBW 2992 in Personalising Lung Cancer Care - The First Presentation of Data From BIBF 1120 in Ovarian Cancer Boehringer Ingelheim ...
London (ots/PRNewswire) - Perenco Ecuador Limited ("Perenco") announced today that on May 8, 2009, a three member international arbitration tribunal constituted under the auspices of the International Centre for the Settlement of Investment disputes ("ICSID") unanimously ordered that the Republic of Ecuador and Empresa Estatal Petroleos del Ecuador ("Petroecuador") were restrained from instituting or further ...
Basel, Switzerland (ots/PRNewswire) - - EMBARGOED: Not for publication until: 14 May at 23:00 BST More than 500 scientific abstracts to be presented across 20 types of cancers. Results could significantly improve the way cancer is treated for patients with inoperable stomach cancer; advanced melanoma; lung and breast cancers. To view the Multimedia News ...
San Jose, California (ots/PRNewswire) - - AT73C240 integrates 20-bit Stereo Audio DAC with 90dB dynamic range, together with 1W Power Amplifier Atmel(R) Corporation (Nasdaq: ATML) announced today the release of its AT73C240 Audio Companion IC for portable multimedia applications. Manufactured on Atmel's ...
Maurepas, France (ots/PRNewswire) - Berberine EURL (held by Mr. Frederic Marchal), Amiral Gestion, B&G SARL, Financier John Beslay and Mr. Jean-Sebastien Beslay, current reference shareholders (hereafter referred to as "Reference Shareholders")in Inventoriste with 87.17% of shares and voting rights, granted, ...